負ののれん発生益、製品売上高、新株予約権付社債他2件
- 【期間】
| 年度 | 負ののれん発生益 | 製品売上高 | 新株予約権付社債 | 研究費 | 事業構造改善費用 |
|---|
| 2008/03 | - | | 1973億 | | 150億 | | - | | - | |
| 2009/03 | - | | 1486億 | -24.7% | - | | - | | 72.8億 | |
| 2010/03 | -24.7億 | | 1193億 | -19.7% | - | | - | | 13.1億 | -82.1% |
| 2011/03 | - | | 1962億 | +64.5% | - | | - | | 6.48億 | -50.3% |
| 2012/03 | - | | 1967億 | +0.2% | - | | - | | - | |
| 2013/03 | - | | 1455億 | -26% | - | | 41.9億 | | - | |
| 2014/03 | - | | - | | - | | 33.9億 | -19.1% | - | |
| 2015/03 | -1.81億 | 赤縮 | - | | - | | 38.8億 | +14.7% | - | |
| 2016/03 | - | | - | | - | | 46.4億 | +19.5% | - | |
| 2017/03 | - | | - | | - | | 44.1億 | -5% | - | |
| 2018/03 | - | | - | | - | | 50.5億 | +14.5% | - | |
| 2019/03 | - | | - | | - | | 61.8億 | +22.4% | 10.9億 | +67.7% |
| 2020/03 | - | | - | | - | | 43.4億 | -29.8% | - | |
| 2021/03 | - | | - | | - | | 15.8億 | -63.7% | - | |
| 2022/03 | - | | - | | - | | 27.8億 | +76.2% | - | |
| 2023/03 | - | | - | | - | | 35.8億 | +28.8% | - | |
